Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Stroke is a major cause of death and disability worldwide. Without improvements in prevention, the burden will increase during the next 20 years because of the ageing population, especially in developing countries. Major advances have occurred in secondary prevention during the past three decades, which demonstrate the broader potential to prevent stroke. We review the main medical treatments that should be considered for most patients with transient ischaemic attack or ischaemic stroke in the acute phase and the long term, and draw attention to recent developments.

Original publication




Journal article



Publication Date





1681 - 1692


Acute Disease, Anticoagulants, Antihypertensive Agents, Atrial Fibrillation, Brain Ischemia, Cardiovascular Agents, Cholesterol, HDL, Cholesterol, LDL, Chronic Disease, Developing Countries, Dyslipidemias, Fibrinolytic Agents, Humans, Hypertension, Hypolipidemic Agents, Ischemic Attack, Transient, Predictive Value of Tests, Prognosis, Risk Assessment, Risk Factors, Secondary Prevention, Stroke, Time Factors, Triage